Analysis of core protein clusters identifies candidate variable sites conferring metronidazole resistance inHelicobacter pylori
Authors:
Open Access
- 2 January 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Gastroenterology Report
- Vol. 7 (1) , 42-49
Abstract
Metronidazole is one of the first-line drugs of choice in the standard triple therapy used to eradicate Helicobacter pylori infection. Hence, the global emergence of metronidazole resistance in Hp poses a major challenge to health professionals. Inactivation of RdxA is known to be a major mechanism of conferring metronidazole resistance in H. pylori. However, metronidazole resistance can also arise in H. pylori strains expressing functional RdxA protein, suggesting that there are other mechanisms that may confer resistance to this drug. We performed whole-genome sequencing on 121 H. pylori clinical strains, among which 73 were metronidazole-resistant. Sequence-alignment analysis of core protein clusters derived from clinical strains containing full-length RdxA was performed. Variable sites in each alignment were statistically compared between the resistant and susceptible groups to determine candidate genes along with their respective amino-acid changes that may account for the development of metronidazole resistance in H. pylori. Resistance due to RdxA truncation was identified in 34% of metronidazole-resistant strains. Analysis of core protein clusters derived from the remaining 48 metronidazole-resistant strains and 48 metronidazole-susceptible identified four variable sites significantly associated with metronidazole resistance. These sites included R16H/C in RdxA, D85N in the inner-membrane protein RclC (HP0565), V265I in a biotin carboxylase protein (HP0370) and A51V/T in a putative threonylcarbamoyl–AMP synthase (HP0918). Our approach identified new potential mechanisms for metronidazole resistance in H. pylori that merit further investigation.Keywords
Funding Information
- Shenzhen’s Sanming Project (SZSM201510050)
- University of Malaya-Ministry of Education
- UM-MOE
- High Impact Research
- HIR (UM.C/625/1/HIR/MoE/CHAN13/3, H-50001-A000030)
- National Health and Medical Research Council
- NHMRC
- Sir McFarlane Burnett Fellowship (572723)
- Vice Chancellor of the University of Western Australia
- Western Australian Department of Commerce and Department of Health
- Early Career Research Fellowship
- NHMRC (APP1073250)
This publication has 36 references indexed in Scilit:
- SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell SequencingJournal of Computational Biology, 2012
- Proteinortho: Detection of (Co-)orthologs in large-scale analysisBMC Bioinformatics, 2011
- Two Amino Acids Mutation of Ferric Uptake Regulator Determines Helicobacter pylori Resistance to MetronidazoleAntioxidants & Redox Signaling, 2011
- Characterization of the NAD(P)H oxidase and metronidazole reductase activities of the RdxA nitroreductase of Helicobacter pyloriThe FEBS Journal, 2009
- Mutational Analysis of Metronidazole Resistance in Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Roles of FrxA and RdxA Nitroreductases of Helicobacter pylori in Susceptibility and Resistance to MetronidazoleJournal of Bacteriology, 2001
- Mutations of the Helicobacter pylori Genes rdxA and pbp1 Cause Resistance against Metronidazole and AmoxicillinAntimicrobial Agents and Chemotherapy, 2001
- Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.Sexually Transmitted Infections, 1980
- Susceptibility of Anaerobic Bacteria to Metronidazole: Relative Resistance of Non-Spore-Forming Gram-Positive BaccilliThe Journal of Infectious Diseases, 1975